Attenuated Salmonella Typhimurium delivery of a novel DNA vaccine induces immune responses and provides protection against duck enteritis virus

Veterinary Microbiology

Volumn 186, Issue , 2016, Pages 189-198

  Liu, Xueyan ^a   Liu, Qing ^a   Xiao, Kangpeng ^a   Li, Pei ^a   Liu, Qiong ^a   Zhao, Xinxin ^a   Kong, Qingke ^a  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Attenuated Salmonella; DNA vaccine vector; DNA vaccines; Duck enteritis virus; Oral immunization

Indexed keywords

DNA VACCINE; DUCK ENTERITIS VIRUS VACCINE; ESCHERICHIA COLI ENTEROTOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN Y; INTERLEUKIN 2; LABILE ENTEROTOXIN B SUBUNIT; TGB PROTEIN; UL24 PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; COS 7 CELL LINE; DNA VIRUS; DUCK ENTERITIS VIRUS; DUCK VIRAL ENTERITIS; DUCKLING; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INNATE IMMUNITY; NONHUMAN; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; TRANSIENT EXPRESSION; VECTOR CONTROL; VIRAL GASTROENTERITIS; VIRUS GENOME; ANIMAL; BLOOD; CHLOROCEBUS AETHIOPS; COS CELL LINE; DUCK; ESCHERICHIA COLI; GENE VECTOR; GENETICS; HERPESVIRIDAE INFECTIONS; IMMUNOLOGY; MARDIVIRUS; MORTALITY; MUCOSAL IMMUNITY; POULTRY DISEASES; PROCEDURES; SURVIVAL ANALYSIS; VACCINATION; VETERINARY; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CERCOPITHECUS AETHIOPS; COS CELLS; DUCKS; ESCHERICHIA COLI; GENETIC VECTORS; HERPESVIRIDAE INFECTIONS; IMMUNITY, MUCOSAL; MARDIVIRUS; POULTRY DISEASES; SALMONELLA TYPHIMURIUM; SURVIVAL ANALYSIS; VACCINATION; VACCINES, DNA; VIRAL VACCINES;

EID: 84960081757     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2016.03.001     Document Type: Article

References (44)

1. Aravind S., Kamble N.M., Gaikwad S.S., Shukla S.K., Saravanan R., Dey S., Madhan Mohan C. Protective effects of recombinant glycoprotein D based prime boost approach against duck enteritis virus in mice model. Microb. Pathog. 2015, 88:78-86.
2. Ashraf S., Kong W., Wang S., Yang J., Curtiss R. Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine. Vaccine 2011, 29:3990-4002.
3. Bai Y., Wang J.D., Zhang Z.S., Zhang Y.L. Construction of the attenuated Salmonella typhimurium strain expressing Helicobacter pylori conservative region of adhesin antigen. Sheng Wu Gong Cheng Xue Bao 2003, 19:433-438.
4. Becker P.D., Noerder M., Guzman C.A. Genetic immunization: bacteria as DNA vaccine delivery vehicles. Hum. Vaccin. 2008, 4:189-202.
5. Chen L., Yu B., Hua J., Ye W., Ni Z., Yun T., Deng X., Zhang C. Construction of a full-length infectious bacterial artificial chromosome clone of duck enteritis virus vaccine strain. Virol. J. 2013, 10:328.
6. da Silva A.J., Zangirolami T.C., Novo-Mansur M.T., Giordano Rde C., Martins E.A. Live bacterial vaccine vectors: an overview. Braz. J. Microbiol. 2014, 45:1117-1129.
7. Douce G., Turcotte C., Cropley I., Roberts M., Pizza M., Domenghini M., Rappuoli R., Dougan G. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:1644-1648.
8. Flo J., Tisminetzky S., Baralle F. Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice. Vaccine 2001, 19:1772-1782.
9. Haraga A., Ohlson M.B., Miller S.I. Salmonellae interplay with host cells. Nat. Rev. Microbiol. 2008, 6:53-66.
10. Hassan J.O., Curtiss R. Development and evaluation of an experimental vaccination program using a live avirulent Salmonella typhimurium strain to protect immunized chickens against challenge with homologous and heterologous Salmonella serotypes. Infect. Immun. 1994, 62:5519-5527.
11. Henke A., Rohland N., Zell R., Wutzler P. Co-expression of interleukin-2 by a bicistronic plasmid increases the efficacy of DNA immunization to prevent influenza virus infections. Intervirology 2006, 49:249-252.
12. Jawale C.V., Lee J.H. Characterization of a Salmonella Typhimurium ghost carrying an adjuvant protein as a vaccine candidate for the protection of chickens against virulent challenge. Avian Pathol. 2014, 43:506-513.
13. Jensen T.H., Nielsen L., Aasted B., Pertoldi C., Blixenkrone-Moller M. Canine distemper virus DNA vaccination of mink can overcome interference by maternal antibodies. Vaccine 2015, 33:1375-1381.
14. Jia R., Cheng A., Wang M., Qi X., Zhu D., Ge H., Luo Q., Liu F., Guo Y., Chen X. Development and evaluation of an antigen-capture ELISA for detection of the UL24 antigen of the duck enteritis virus, based on a polyclonal antibody against the UL24 expression protein. J. Virol. Methods 2009, 161:38-43.
15. Jiao H., Pan Z., Yin Y., Geng S., Sun L., Jiao X. Oral and nasal DNA vaccines delivered by attenuated Salmonella enterica serovar Typhimurium induce a protective immune response against infectious bronchitis in chickens. Clin. Vaccine Immunol. 2011, 18:1041-1045.
16. Keel M.K., Stallknecht D., Cobb D., Cunningham M., Goekjian V., Gordon-Akhvlediani S., Fischer J.R. The epizootiology of anatid herpesvirus 1 infection in free-flying waterfowl: a comparison of latent and active infections among native waterfowl, captive-reared released ducks, and peridomestic or feral ducks. J. Wildl. Dis. 2013, 49:486-491.
17. Kong Q., Yang J., Liu Q., Alamuri P., Roland K.L., Curtiss R., 3rd Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium. Infect. Immun. 2011, 79:4227-4239.
18. Li Y., Huang B., Ma X., Wu J., Li F., Ai W., Song M., Yang H. Molecular characterization of the genome of duck enteritis virus. Virology 2009, 391:151-161.
19. Li Y., Wang S., Scarpellini G., Gunn B., Xin W., Wanda S.Y., Roland K.L., Curtiss R. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:593-598.
20. Mondal B., Rasool T.J., Ram H., Mallanna S. Propagation of vaccine strain of duck enteritis virus in a cell line of duck origin as an alternative production system to propagation in embryonated egg. Biologicals 2010, 38:401-406.
21. Moyle P.M. Progress in vaccine development. Curr. Protoc. Microbiol. 2015, 36. 18.11.11-18.11.26.
22. Naderi M., Gholipour N., Zolfaghari M.R., Moradi Binabaj M., Yegane Moghadam A., Motalleb G. Hepatitis C virus and vaccine development. Int. J. Mol. Cell. Med. 2014, 3:207-215.
23. Pradhan S.N., Prince P.R., Madhumathi J., Arunkumar C., Roy P., Narayanan R.B., Antony U. DNA vaccination with VP2 gene fragment confers protection against Infectious Bursal Disease Virus in chickens. Vet. Microbiol. 2014, 171:13-22.
24. Qi X., Yang X., Cheng A., Wang M., Zhu D., Jia R., Luo Q., Chen X. Intestinal mucosal immune response against virulent duck enteritis virus infection in ducklings. Res. Vet. Sci. 2009, 87:218-225.
25. Qiu Y., Guo L., Zhang S., Xu B., Gao Y., Hu Y., Hou J., Bai B., Shen H., Mao P. DNA-based vaccination against hepatitis B virus using dissolving micromeedle arrays adjuvanted by cationic liposomes and CpG ODN. Drug Deliv. 2015, 25:1-8.
26. Roland K., Curtiss R., Sizemore D. Construction and evaluation of a delta cya delta crp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Dis. 1999, 43:429-441.
27. Saade F., Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Rev. Vaccines 2012, 11:189-209.
28. Sallberg M., Frelin L., Ahlen G., Sallberg-Chen M. Electroporation for therapeutic DNA vaccination in patients. Med. Microbiol. Immunol. 2015, 204:131-135.
29. Shawky S., Schat K.A. Latency sites and reactivation of duck enteritis virus. Avian Dis. 2002, 46:308-313.
30. Stachyra A., Gora-Sochacka A., Sirko A. DNA vaccines against influenza. Acta Biochim. Pol. 2014, 61:515-522.
31. Tacket C.O., Kelly S.M., Schodel F., Losonsky G., Nataro J.P., Edelman R., Levine M.M., Curtiss 3rd R. Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Infect. Immun. 1997, 65:3381-3385.
32. Toussaint B., Chauchet X., Wang Y., Polack B., Le Gouellec A. Live-attenuated bacteria as a cancer vaccine vector. Expert Rev. Vaccines 2013, 12:1139-1154.
33. Wang M., Lin D., Zhang S., Zhu D., Jia R., Chen X., Cheng A. Prokaryotic expression of the truncated duck enteritis virus UL27 gene and characteristics of UL27 gene and its truncated product. Acta Virol. 2012, 56:323-328.
34. Wang J., Ge A., Xu M., Wang Z., Qiao Y., Gu Y., Liu C., Liu Y., Hou J. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens. Virol. J. 2015, 12:126.
35. Weingarten M. Duck plague: clinical aspects, diagnosis, control. Tierarztl. Prax. 1989, 17:53-56.
36. Wen J., Yang Y., Zhao G., Tong S., Yu H., Jin X., Du L., Jiang S., Kou Z., Zhou Y. Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway. Vaccine 2012, 30:5733-5739.
37. Wozniakowski G., Samorek-Salamonowicz E. First survey of the occurrence of duck enteritis virus (DEV) in free-ranging Polish water birds. Arch. Virol 2014, 159:1439-1444.
38. Yang X., Qi X., Cheng A., Wang M., Zhu D., Jia R., Chen X. Intestinal mucosal immune response in ducklings following oral immunisation with an attenuated Duck enteritis virus vaccine. Vet. J. 2010, 185:199-203.
39. Yang B., Jeang J., Yang A., Wu T.C., Hung C.F. DNA vaccine for cancer immunotherapy. Hum. Vaccine Immunother. 2014, 10:3153-3164.
40. Young J.L., Benoit J.N., Dean D.A. Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature. Gene Ther. 2003, 10:1465-1470.
41. Zhang Z.S., Weng Y.W., Huang H.L., Zhang J.M., Yan Y.S. Neutralizing antibodies respond to a bivalent dengue DNA vaccine or/and a recombinant bivalent antigen. Mol. Med. Rep. 2015, 11:1009-1016.
42. Zhao K., Li W., Huang T., Luo X., Chen G., Zhang Y., Guo C., Dai C., Jin Z., Zhao Y., Cui H., Wang Y. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticles. PLoS One 2013, 8:e82648.
43. Zhao Y., Cao Y., Cui L., Ma B., Mu X., Li Y., Zhang Z., Li D., Wei W., Gao M., Wang J. Duck enteritis virus glycoprotein D and B DNA vaccines induce immune responses and immunoprotection in Pekin ducks. PLoS One 2014, 9:e95093.
44. Zou Z., Hu Y., Liu Z., Zhong W., Cao H., Chen H., Jin M. Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection. Vet. Res. 2015, 46:42.